loanDepot, Inc. (NYSE:LDI – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 1,430,000 shares, a decline of 15.9% from the November 15th total of 1,700,000 shares. Approximately 2.0% of the company’s shares are short sold. Based on an average trading volume of 866,100 shares, the short-interest ratio is presently 1.7 days.
Analysts Set New Price Targets
A number of research firms have recently issued reports on LDI. The Goldman Sachs Group increased their target price on loanDepot from $1.70 to $2.70 and gave the company a “sell” rating in a research note on Thursday, November 14th. UBS Group increased their price objective on shares of loanDepot from $2.30 to $2.50 and gave the company a “neutral” rating in a research report on Thursday, September 5th.
Check Out Our Latest Report on loanDepot
loanDepot Stock Performance
Insider Buying and Selling at loanDepot
In other news, insider Jeff Alexander Walsh sold 36,811 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $2.66, for a total value of $97,917.26. Following the completion of the sale, the insider now owns 4,035,317 shares of the company’s stock, valued at $10,733,943.22. This represents a 0.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Anthony Li Hsieh sold 106,784 shares of loanDepot stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $2.17, for a total transaction of $231,721.28. Following the transaction, the director now owns 3,560,584 shares in the company, valued at $7,726,467.28. The trade was a 2.91 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,085,785 shares of company stock valued at $2,424,974. Company insiders own 83.04% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Wolverine Asset Management LLC increased its holdings in loanDepot by 6.0% during the 2nd quarter. Wolverine Asset Management LLC now owns 1,019,910 shares of the company’s stock worth $1,683,000 after purchasing an additional 57,546 shares during the last quarter. American Century Companies Inc. grew its position in shares of loanDepot by 27.3% during the second quarter. American Century Companies Inc. now owns 91,701 shares of the company’s stock worth $151,000 after buying an additional 19,655 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of loanDepot by 390.6% in the second quarter. Dimensional Fund Advisors LP now owns 198,724 shares of the company’s stock worth $328,000 after buying an additional 158,221 shares during the last quarter. 272 Capital LP raised its holdings in loanDepot by 107.4% in the second quarter. 272 Capital LP now owns 183,190 shares of the company’s stock valued at $302,000 after acquiring an additional 94,883 shares in the last quarter. Finally, Park Avenue Securities LLC acquired a new stake in loanDepot in the third quarter valued at $27,000. Hedge funds and other institutional investors own 39.39% of the company’s stock.
About loanDepot
loanDepot, Inc engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity loans. It also provides settlement services, which include captive title and escrow business; real estate services that cover captive real estate referral business; and insurance services, including services to homeowners, as well as other consumer insurance policies.
Further Reading
- Five stocks we like better than loanDepot
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Calculate Options Profits
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Want to Profit on the Downtrend? Downtrends, Explained.
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for loanDepot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for loanDepot and related companies with MarketBeat.com's FREE daily email newsletter.